Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
372.89B
Market cap372.89B
Price-Earnings ratio
121.65
Price-Earnings ratio121.65
Dividend yield
2.21%
Dividend yield2.21%
Average volume
10.45M
Average volume10.45M
High today
$152.52
High today$152.52
Low today
$148.52
Low today$148.52
Open price
$150.78
Open price$150.78
Volume
6.84M
Volume6.84M
52 Week high
$153.50
52 Week high$153.50
52 Week low
$77.58
52 Week low$77.58

Stock Snapshot

Merck(MRK) stock is priced at $151.14, giving the company a market capitalization of 372.89B. It carries a P/E multiple of 121.65 and pays a dividend yield of 2.21%.

During the trading session on 2026-08-20, Merck(MRK) shares reached a daily high of $152.52 and a low of $148.52. At a current price of $151.14, the stock is +1.8% higher than the low and still -0.9% under the high.

Trading activity shows a volume of 6.84M, compared to an average daily volume of 10.45M.

The stock's 52-week range extends from a low of $77.58 to a high of $153.50.

The stock's 52-week range extends from a low of $77.58 to a high of $153.50.

MRK News

Barron's 52m
Merck Stock Gets Downgrade After Cancer Win With Moderna - Barron's

...

Merck Stock Gets Downgrade After Cancer Win With Moderna - Barron's
24/7 Wall St. 59m
Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips

Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips By David Moadel Published Aug 20, 11:23AM EDT Quick Read Moderna (MRNA) drop...

Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips
TipRanks 3h
Etsy upgraded, TJX downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as...

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
29%
Sell
3.2%

More MRK News

Simply Wall St 3h
Executive VP & President of Merck Animal Health Richard DeLuca Sold A Bunch Of Shares In Merck

We wouldn't blame Merck & Co., Inc. ( ) shareholders if they were a little worried about the fact that Richard DeLuca, the Executive VP & President of Merck Ani...

Executive VP & President of Merck Animal Health Richard DeLuca Sold A Bunch Of Shares In Merck
TipRanks 6h
Merck price target raised to $175 from $145 at UBS

UBS raised the firm’s price target on Merck (MRK) to $175 from $145 and keeps a Buy rating on the shares. Moderna (MRNA) and Merck surged 176% and 12%, respecti...

TipRanks 6h
RBC downgrades Merck on ‘unprecedented valuation’ after vaccine data

RBC Capital analyst Trung Huynh downgraded Merck (MRK) to Sector Perform from Outperform with a price target of $150, up from $142. Merck’s cancer vaccine data...

The Motley Fool 16h
Why Moderna Stock Skyrocketed Today

Shares of Moderna (MRNA +176.97%) soared on Wednesday after the vaccine maker announced potentially game-changing progress in the fight against cancer. Landmark...

Why Moderna Stock Skyrocketed Today
Nasdaq 19h
Stock Market Today, Aug. 19: Stocks Edge Higher, Ending 3-Day Losing Streak

The Dow Jones Industrial Average (DJINDICES:^DJI) rose 0.22% to 53,463, the S&P 500 (SNPINDEX:^GSPC) gained 0.21% to 7,708, and the Nasdaq Composite (NASDAQINDE...

Stock Market Today, Aug. 19: Stocks Edge Higher, Ending 3-Day Losing Streak
Nasdaq 20h
Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

Shares of Moderna MRNA) and Merck MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their personalized mRNA cancer...

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?
MarketWatch 21h
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally

The stocks of five of the world’s largest drugmakers are on track for a record close. AbbVie’s shares ABBV were up 2.6% on Wednesday, while Amgen AMGN gained 3...

Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.